1. Home
  2. RYTM vs IRT Comparison

RYTM vs IRT Comparison

Compare RYTM & IRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • IRT
  • Stock Information
  • Founded
  • RYTM 2008
  • IRT 2009
  • Country
  • RYTM United States
  • IRT United States
  • Employees
  • RYTM N/A
  • IRT N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • IRT Real Estate Investment Trusts
  • Sector
  • RYTM Health Care
  • IRT Real Estate
  • Exchange
  • RYTM Nasdaq
  • IRT Nasdaq
  • Market Cap
  • RYTM 4.3B
  • IRT 4.3B
  • IPO Year
  • RYTM 2017
  • IRT 2013
  • Fundamental
  • Price
  • RYTM $61.99
  • IRT $17.73
  • Analyst Decision
  • RYTM Strong Buy
  • IRT Buy
  • Analyst Count
  • RYTM 12
  • IRT 10
  • Target Price
  • RYTM $76.75
  • IRT $22.70
  • AVG Volume (30 Days)
  • RYTM 525.0K
  • IRT 1.9M
  • Earning Date
  • RYTM 08-05-2025
  • IRT 07-30-2025
  • Dividend Yield
  • RYTM N/A
  • IRT 3.84%
  • EPS Growth
  • RYTM N/A
  • IRT N/A
  • EPS
  • RYTM N/A
  • IRT 0.13
  • Revenue
  • RYTM $136,863,000.00
  • IRT $641,330,000.00
  • Revenue This Year
  • RYTM $37.56
  • IRT $5.23
  • Revenue Next Year
  • RYTM $74.99
  • IRT $6.20
  • P/E Ratio
  • RYTM N/A
  • IRT $136.48
  • Revenue Growth
  • RYTM 48.88
  • IRT N/A
  • 52 Week Low
  • RYTM $39.46
  • IRT $17.10
  • 52 Week High
  • RYTM $69.89
  • IRT $22.26
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 47.67
  • IRT 35.61
  • Support Level
  • RYTM $60.70
  • IRT $17.74
  • Resistance Level
  • RYTM $62.65
  • IRT $18.02
  • Average True Range (ATR)
  • RYTM 2.39
  • IRT 0.37
  • MACD
  • RYTM -0.52
  • IRT -0.04
  • Stochastic Oscillator
  • RYTM 14.04
  • IRT 10.22

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About IRT Independence Realty Trust Inc.

Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.

Share on Social Networks: